[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369806-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-369806-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","targeting-fcrla-to-induce-necrosis-in-lung-adenocarcinoma-a-novel-strategy-for-prognosis-and-therapy-via-mpt-driven-pathways","Targeting FCRLA to induce necrosis in lung adenocarcinoma - a novel strategy for prognosis and therapy via MPT-driven pathways","","A study examines how MPT-driven necrosis (MPTDN) related genes contribute to lung adenocarcinoma (LUAD) and why FCRLA may represent a regulatory target. Using TCGA-LUAD and GSE31210, differential expression and weighted gene co-expression network analysis identified candidate genes and refined prognostic candidates including FCRLA. In vitro LUAD models with FCRLA knockdown reduced proliferation and triggered necrosis. Electron microscopy and JC-1 assays showed disrupted mitochondrial structure and reduced membrane potential, supporting impaired mitochondrial function. The work links FCRLA to MPTDN-associated pathways, suggesting therapeutic potential for LUAD.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-fcrla-to-induce-necrosis-in-lung-adenocarcinoma-a-novel-strategy-for-prognosis-and-therapy-via-mpt-driven-pathways/369806/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-fcrla-to-induce-necrosis-in-lung-adenocarcinoma-a-novel-strategy-for-prognosis-and-therapy-via-mpt-driven-pathways/369806.png","ImageObject",300,407,{"name":42,"@type":43},"McGucket","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about FCRLA and LUAD?","Question",{"text":63,"@type":64},"It investigates the regulatory mechanisms of MPTDN-related genes in lung adenocarcinoma and focuses on whether FCRLA can drive necrosis as part of MPT-driven pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were candidate genes and FCRLA identified?",{"text":68,"@type":64},"Genes from TCGA-LUAD were intersected via differential expression analysis and weighted gene co-expression network analysis (WGCNA), leading to candidate genes and further prognostic screening to highlight FCRLA.",{"name":70,"@type":61,"acceptedAnswer":71},"What happens to LUAD cells after FCRLA knockdown?",{"text":72,"@type":64},"FCRLA knockdown significantly inhibits LUAD cell proliferation and induces necrosis, accompanied by disrupted mitochondrial structure and reduced mitochondrial membrane potential.",{"name":74,"@type":61,"acceptedAnswer":75},"What experimental evidence supports mitochondrial dysfunction in this mechanism?",{"text":76,"@type":64},"Electron microscopy showed mitochondrial structural disruption after FCRLA knockdown, and JC-1 probe measurements revealed a significant reduction in mitochondrial membrane potential, indicating impaired mitochondrial function.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},369806,1791086503,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Original Research PUBLISHED 13 August 2025  \nDOI 10.3389/fimmu.2025.1596179  \nOPEN ACCESS  \nEDITED BY  \nArumugam Jayakumar,  \nUniversity of Texas MD Anderson Cancer Center, United States  \nREVIEWED BY  \nGuillaume Gaud,  \nNational Institutes of Health (NIH), United States  \nMin Tang,  \nChongqing University, China Bin Zhou,  \nJiangsu Institute of Cancer Research, China  \n*CORRESPONDENCE  \nZhigang Cai  \n [zhigang_cai@hebmu.edu.cn](zhigang_cai@hebmu.edu.cn)  \nRECEIVED 19 March 2025  \nACCEPTED 25 July 2025  \nPUBLISHED 13 August 2025  \nCITATION  \nSun X, Cai B, Zhang S, Cao X, Wang Z and Cai Z (2025) Targeting FCRLA to induce necrosis in lung adenocarcinoma: a novel strategy for prognosis and therapy via MPT-Driven pathways.  \nFront. Immunol. 16:1596179 .  \ndoi: 10.3389/fimmu.2025.1596179  \nCOPYRIGHT  \n© 2025 Sun, Cai, Zhang, Cao, Wang and Cai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTargeting FCRLA to induce necrosis in lung adenocarcinoma: a novel strategy for prognosis and therapy via MPTDriven pathways  \nXiaoli Sun 1,2,3,4, Bowen Cai 5, Shusen Zhang 6, Xiaowei Cao 2, Zhen Wang 2 and Zhigang Cai 1,3,4*  \n1The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China, 2 Department of Pulmonary and Critical Care Medicine, Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China, 3 Hebei Key Laboratory of Respiratory Critical Care Medicine, Shijiazhuang, Hebei, China, 4 Hebei Institute of Respiratory Diseases, Shijiazhuang, Hebei, China, 5 Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China, 6 Department of Pulmonary and Critical Care Medicine, Xing tai People’s Hospital, Xingtai, Hebei, China  \nIntroduction: The induction of mitochondrial permeability transition-driven necrosis (MPTDN) is therapeutically relevant in various cancers. However, few studies have explored the role of MPTDN-related genes (MPTDNRGs) in lung adenocarcinoma (LUAD) . Therefore, this study investigated the regulatory mechanisms of MPTDNRGs in LUAD.  \nMethods: This study was based on The Cancer Genome Atlas-Lung Adenocarcinoma (TCGA-LUAD), GSE31210, and MPTDNRGs. First, the genes obtained from TCGA-LUAD were intersected through differential expression analysis and weighted gene co-expression network analysis (WGCNA) to obtain the candidate FCRLA gene. An FCRLA knockdown cell model was constructed in vitro using LUAD cells, and cell-related phenotypic experiments, including proliferation and apoptosis, were performed. The integrity of the mitochondrial structure was observed using electron microscopy, and the mitochondrial membrane potential was detected using a JC-1 probe.  \nResults: A total of 82 candidate genes were identiﬁed by intersecting 3,231 differentially expressed genes with 566 key module genes. Subsequently, three prognostic genes (RASGRP2, CD79A, and FCRLA) were further screened. CD79A and FCRLA were signiﬁcantly expressed in the LUAD group, whereas the opposite was true for RASGRP2 . In vitro studies indicated that FCRLA knockdown signiﬁcantly inhibited the proliferation of LUAD cells and induced necrosis in these cells. Electron microscopy found that the mitochondrial structure was disrupted after FCRLA knockdown . The JC-1 probe indicated that the  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nmitochondrial membrane potential in the FCRLA-knockdown group was signiﬁcantly reduced, suggesting impaired mitochondrial function.  \nDiscussion: RASGRP2 , CD79A, and FCRLA have been identiﬁed as being as","cbCail4hY429NKEZ","https://ap.wps.com/l/cbCail4hY429NKEZ","pdf",16339021,"English","# Introduction\n## Background and rationale\n# Methods\n## Dataset selection and gene identification\n## Cell model and phenotypic assays\n## Mitochondrial assessment\n# Results\n## Candidate gene discovery and prognostic screening\n## Cellular effects of FCRLA knockdown\n## Mitochondrial structural and functional changes\n# Discussion\n## Implications for MPTDN pathways and therapy","[{\"question\":\"What question does the study address about FCRLA and LUAD?\",\"answer\":\"It investigates the regulatory mechanisms of MPTDN-related genes in lung adenocarcinoma and focuses on whether FCRLA can drive necrosis as part of MPT-driven pathways.\"},{\"question\":\"How were candidate genes and FCRLA identified?\",\"answer\":\"Genes from TCGA-LUAD were intersected via differential expression analysis and weighted gene co-expression network analysis (WGCNA), leading to candidate genes and further prognostic screening to highlight FCRLA.\"},{\"question\":\"What happens to LUAD cells after FCRLA knockdown?\",\"answer\":\"FCRLA knockdown significantly inhibits LUAD cell proliferation and induces necrosis, accompanied by disrupted mitochondrial structure and reduced mitochondrial membrane potential.\"},{\"question\":\"What experimental evidence supports mitochondrial dysfunction in this mechanism?\",\"answer\":\"Electron microscopy showed mitochondrial structural disruption after FCRLA knockdown, and JC-1 probe measurements revealed a significant reduction in mitochondrial membrane potential, indicating impaired mitochondrial function.\"}]","Targeting FCRLA to induce necrosis in lung adenocarcinoma - a novel strategy for prognosis and therapy via MPT-driven pathways | PDF",1790184645,48,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4266097348d5d14389d606b57d4a84f5.webp",983,1389,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e95c68dc794cbac1be5d6972815ac0fe.webp",982,1388,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72b47e75460578485d3128ee035f8d79.webp",981,1387,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70a69814708839b6c891cbaa20a0d3bf.webp",980,1385]